Fundraising Fox
SetPoint Medical
Valencia, US · 125 employees on LinkedIn · 15 known investors
Find your way into SetPoint Medical
Sign up to see every warm intro you have to SetPoint Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SetPoint Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs. The company applies this "neuroimmune modulation" approach to autoimmune disease care.
Founders & leadership
Board
Investors · 15
How we know: Ally Bridge Group's portfolio page · the company's own site · Not right? Tell us
How we know: the company's own site · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Norwest Venture Partners's portfolio page · the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: Asahi Kasei Corporate Venture Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us
How we know: Lightstone Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Runway Growth Capital's portfolio page · Not right? Tell us
How we know: ShangBay Capital LLC's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: Viking Global's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$290.8M disclosed across 5 rounds · 2015–2025
▶$115.5MraisedOct 2025 · 24 investors · Other Health CareRule 506(b)
- David ChernoffExecutive Officer
- Murthy SimhambhatlaExecutive Officer, Director
- Zack ScottDirector
- Allan WillDirector
- Steven J WinickDirector
- Rohan SethExecutive Officer
- Tyler BinneyDirector
- Kevin ReillyDirector
- Hank PlainDirector
- Blake WuDirector
- Josh MakowerDirector
- Juan-Pablo MasDirector
- Offering amount
- $115.5M
- Amount sold
- $115.5M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$80MraisedFeb 2025 · 21 investors · Other Health CareRule 506(b)
- Blake WuDirector
- Murthy SimhambhatlaExecutive Officer, Director
- David ChernoffExecutive Officer
- Juan-Pablo MasDirector
- Rohan SethExecutive Officer
- Zack ScottDirector
- Steven J WinickDirector
- Allan WillDirector
- Hank PlainDirector
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$64.4MraisedFeb 2021 · 26 investors · Other Health CareRule 506(b)
- Josh MakowerDirector
- Murthy SimhambhatlaExecutive Officer, Director
- Alan WillDirector
- Hank PlainDirector
- Juan-Pablo MasDirector
- Colin MorrisonDirector
- Steven J. WinickDirector
- William DaiDirector
- Offering amount
- $64.4M
- Amount sold
- $64.4M
- Minimum investment
- $1
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.7MraisedSep 2019 · 8 investors · Other Health CareRule 506(b)
- Joe BillerDirector
- Steven J. WinickDirector
- Allan WillDirector
- Hank PlainDirector
- Juan-Pablo MasDirector
- Josh MakowerDirector
- Murthy SimhambhatlaExecutive Officer, Director
- Offering amount
- $20.5M
- Amount sold
- $15.7M
- Minimum investment
- $1
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.1MraisedSep 2015 · 7 investors · BiotechnologyRule 506(b)
- Hank PlainDirector
- David NeustaedterDirector
- Bill GearyDirector
- Juan-Pablo MasDirector
- Anthony ArnoldExecutive Officer, Director
- Alan WillDirector
- Christopher KasterDirector
- Steven WinickDirector
- Offering amount
- $15.1M
- Amount sold
- $15.1M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through SetPoint Medical went on to found or lead other companies.
Related companies · 2
Companies working in the same space as SetPoint Medical.
Frequently asked questions
- What does SetPoint Medical do?
- SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs. The company applies this "neuroimmune modulation" approach to autoimmune disease care.
- Who are SetPoint Medical's investors?
- SetPoint Medical's investors include Ally Bridge Group, New Enterprise Associates (NEA), Norwest Venture Partners, Topspin Partners, Asahi Kasei Corporate Venture Capital, Catalio Capital Management, LP, Citta Capital, Lightstone Ventures and 7 more.
- How much funding has SetPoint Medical raised?
- SetPoint Medical has disclosed $290.8M raised across 5 rounds.
- Where is SetPoint Medical headquartered?
- SetPoint Medical is headquartered in Valencia, US.